Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +55.89%
#3 DOVU DOVU +48.37%
#4 Velvet Velvet +44.60%
#5 Black Phoenix Black Phoenix +34.05%
#6 Cross Cross +27.56%
#7 Cap Cap +19.95%
#8 DoubleZero DoubleZero +17.42%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.92%
#10 Pieverse Pieverse +9.84%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Rang in aandelen #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Aandeelprijs
$2.06
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$572.30K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-90.38%
Land
CA
Handel XORTX Therapeutics Inc. (XRTX)

Categorie

Healthcare
Aandelsplitsingen voor XORTX Therapeutics Inc. (XRTX)
Het aandeel XORTX Therapeutics Inc. (symbool: XRTX) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 14, 2026.
Eén aandeel XRTX dat vóór Aug 14, 2026 werd gekocht, staat nu gelijk aan 0 aandelen XRTX.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE